Global Biologic Medications for Psoriasis Market Research Report 2025(Status and Outlook)
Report Overview
Biologic medications for psoriasis are advanced therapeutic agents derived from living organisms that specifically target and modulate the immune system's activity involved in the disease.These medications are typically used for moderate to severe psoriasis and are administered through injections or infusions.
This report provides a deep insight into the global Biologic Medications for Psoriasis market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Biologic Medications for Psoriasis Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Biologic Medications for Psoriasis market in any manner.
Global Biologic Medications for Psoriasis Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Bristol-Myers Squibb
Amgen
Tiefenbacher Pharmaceuticals
UCB
Janssen Biotech
Eli Lilly
AbbVie Biotechnology
Dalian Yawei Pharmaceutical
Novartis
Ortho Dermatologics
LEO Pharma
Kyowa Kirin
Boehringer Ingelheim Pharmaceuticals
Pfizer
Samsung Bioepis
Qilu Pharmaceutical
Hanwha Chemical
China Medical System
Market Segmentation (by Type)
TNF-? Inhibitors
Interleukin Inhibitors
Tyrosine Kinase Inhibitors
Phosphodiesterase Inhibitors
Other
Market Segmentation (by Application)
Hospital and Clinic
Retail Pharmacies
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Biologic Medications for Psoriasis Market
Overview of the regional outlook of the Biologic Medications for Psoriasis Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Biologic Medications for Psoriasis Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Biologic Medications for Psoriasis, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Biologic medications for psoriasis are advanced therapeutic agents derived from living organisms that specifically target and modulate the immune system's activity involved in the disease.These medications are typically used for moderate to severe psoriasis and are administered through injections or infusions.
This report provides a deep insight into the global Biologic Medications for Psoriasis market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Biologic Medications for Psoriasis Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Biologic Medications for Psoriasis market in any manner.
Global Biologic Medications for Psoriasis Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Bristol-Myers Squibb
Amgen
Tiefenbacher Pharmaceuticals
UCB
Janssen Biotech
Eli Lilly
AbbVie Biotechnology
Dalian Yawei Pharmaceutical
Novartis
Ortho Dermatologics
LEO Pharma
Kyowa Kirin
Boehringer Ingelheim Pharmaceuticals
Pfizer
Samsung Bioepis
Qilu Pharmaceutical
Hanwha Chemical
China Medical System
Market Segmentation (by Type)
TNF-? Inhibitors
Interleukin Inhibitors
Tyrosine Kinase Inhibitors
Phosphodiesterase Inhibitors
Other
Market Segmentation (by Application)
Hospital and Clinic
Retail Pharmacies
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Biologic Medications for Psoriasis Market
Overview of the regional outlook of the Biologic Medications for Psoriasis Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Biologic Medications for Psoriasis Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Biologic Medications for Psoriasis, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Biologic Medications for Psoriasis
1.2 Key Market Segments
1.2.1 Biologic Medications for Psoriasis Segment by Type
1.2.2 Biologic Medications for Psoriasis Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 BIOLOGIC MEDICATIONS FOR PSORIASIS MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 BIOLOGIC MEDICATIONS FOR PSORIASIS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Biologic Medications for Psoriasis Product Life Cycle
3.3 Global Biologic Medications for Psoriasis Revenue Market Share by Company (2020-2025)
3.4 Biologic Medications for Psoriasis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 Biologic Medications for Psoriasis Company Headquarters, Area Served, Product Type
3.6 Biologic Medications for Psoriasis Market Competitive Situation and Trends
3.6.1 Biologic Medications for Psoriasis Market Concentration Rate
3.6.2 Global 5 and 10 Largest Biologic Medications for Psoriasis Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 BIOLOGIC MEDICATIONS FOR PSORIASIS VALUE CHAIN ANALYSIS
4.1 Biologic Medications for Psoriasis Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF BIOLOGIC MEDICATIONS FOR PSORIASIS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Biologic Medications for Psoriasis Market Porter's Five Forces Analysis
6 BIOLOGIC MEDICATIONS FOR PSORIASIS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Biologic Medications for Psoriasis Market Size Market Share by Type (2020-2025)
6.3 Global Biologic Medications for Psoriasis Market Size Growth Rate by Type (2021-2025)
7 BIOLOGIC MEDICATIONS FOR PSORIASIS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Biologic Medications for Psoriasis Market Size (M USD) by Application (2020-2025)
7.3 Global Biologic Medications for Psoriasis Sales Growth Rate by Application (2020-2025)
8 BIOLOGIC MEDICATIONS FOR PSORIASIS MARKET SEGMENTATION BY REGION
8.1 Global Biologic Medications for Psoriasis Market Size by Region
8.1.1 Global Biologic Medications for Psoriasis Market Size by Region
8.1.2 Global Biologic Medications for Psoriasis Market Size Market Share by Region
8.2 North America
8.2.1 North America Biologic Medications for Psoriasis Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Biologic Medications for Psoriasis Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Spain
8.4 Asia Pacific
8.4.1 Asia Pacific Biologic Medications for Psoriasis Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Biologic Medications for Psoriasis Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Biologic Medications for Psoriasis Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Bristol-Myers Squibb
9.1.1 Bristol-Myers Squibb Basic Information
9.1.2 Bristol-Myers Squibb Biologic Medications for Psoriasis Product Overview
9.1.3 Bristol-Myers Squibb Biologic Medications for Psoriasis Product Market Performance
9.1.4 Bristol-Myers Squibb SWOT Analysis
9.1.5 Bristol-Myers Squibb Business Overview
9.1.6 Bristol-Myers Squibb Recent Developments
9.2 Amgen
9.2.1 Amgen Basic Information
9.2.2 Amgen Biologic Medications for Psoriasis Product Overview
9.2.3 Amgen Biologic Medications for Psoriasis Product Market Performance
9.2.4 Amgen SWOT Analysis
9.2.5 Amgen Business Overview
9.2.6 Amgen Recent Developments
9.3 Tiefenbacher Pharmaceuticals
9.3.1 Tiefenbacher Pharmaceuticals Basic Information
9.3.2 Tiefenbacher Pharmaceuticals Biologic Medications for Psoriasis Product Overview
9.3.3 Tiefenbacher Pharmaceuticals Biologic Medications for Psoriasis Product Market Performance
9.3.4 Tiefenbacher Pharmaceuticals SWOT Analysis
9.3.5 Tiefenbacher Pharmaceuticals Business Overview
9.3.6 Tiefenbacher Pharmaceuticals Recent Developments
9.4 UCB
9.4.1 UCB Basic Information
9.4.2 UCB Biologic Medications for Psoriasis Product Overview
9.4.3 UCB Biologic Medications for Psoriasis Product Market Performance
9.4.4 UCB Business Overview
9.4.5 UCB Recent Developments
9.5 Janssen Biotech
9.5.1 Janssen Biotech Basic Information
9.5.2 Janssen Biotech Biologic Medications for Psoriasis Product Overview
9.5.3 Janssen Biotech Biologic Medications for Psoriasis Product Market Performance
9.5.4 Janssen Biotech Business Overview
9.5.5 Janssen Biotech Recent Developments
9.6 Eli Lilly
9.6.1 Eli Lilly Basic Information
9.6.2 Eli Lilly Biologic Medications for Psoriasis Product Overview
9.6.3 Eli Lilly Biologic Medications for Psoriasis Product Market Performance
9.6.4 Eli Lilly Business Overview
9.6.5 Eli Lilly Recent Developments
9.7 AbbVie Biotechnology
9.7.1 AbbVie Biotechnology Basic Information
9.7.2 AbbVie Biotechnology Biologic Medications for Psoriasis Product Overview
9.7.3 AbbVie Biotechnology Biologic Medications for Psoriasis Product Market Performance
9.7.4 AbbVie Biotechnology Business Overview
9.7.5 AbbVie Biotechnology Recent Developments
9.8 Dalian Yawei Pharmaceutical
9.8.1 Dalian Yawei Pharmaceutical Basic Information
9.8.2 Dalian Yawei Pharmaceutical Biologic Medications for Psoriasis Product Overview
9.8.3 Dalian Yawei Pharmaceutical Biologic Medications for Psoriasis Product Market Performance
9.8.4 Dalian Yawei Pharmaceutical Business Overview
9.8.5 Dalian Yawei Pharmaceutical Recent Developments
9.9 Novartis
9.9.1 Novartis Basic Information
9.9.2 Novartis Biologic Medications for Psoriasis Product Overview
9.9.3 Novartis Biologic Medications for Psoriasis Product Market Performance
9.9.4 Novartis Business Overview
9.9.5 Novartis Recent Developments
9.10 Ortho Dermatologics
9.10.1 Ortho Dermatologics Basic Information
9.10.2 Ortho Dermatologics Biologic Medications for Psoriasis Product Overview
9.10.3 Ortho Dermatologics Biologic Medications for Psoriasis Product Market Performance
9.10.4 Ortho Dermatologics Business Overview
9.10.5 Ortho Dermatologics Recent Developments
9.11 LEO Pharma
9.11.1 LEO Pharma Basic Information
9.11.2 LEO Pharma Biologic Medications for Psoriasis Product Overview
9.11.3 LEO Pharma Biologic Medications for Psoriasis Product Market Performance
9.11.4 LEO Pharma Business Overview
9.11.5 LEO Pharma Recent Developments
9.12 Kyowa Kirin
9.12.1 Kyowa Kirin Basic Information
9.12.2 Kyowa Kirin Biologic Medications for Psoriasis Product Overview
9.12.3 Kyowa Kirin Biologic Medications for Psoriasis Product Market Performance
9.12.4 Kyowa Kirin Business Overview
9.12.5 Kyowa Kirin Recent Developments
9.13 Boehringer Ingelheim Pharmaceuticals
9.13.1 Boehringer Ingelheim Pharmaceuticals Basic Information
9.13.2 Boehringer Ingelheim Pharmaceuticals Biologic Medications for Psoriasis Product Overview
9.13.3 Boehringer Ingelheim Pharmaceuticals Biologic Medications for Psoriasis Product Market Performance
9.13.4 Boehringer Ingelheim Pharmaceuticals Business Overview
9.13.5 Boehringer Ingelheim Pharmaceuticals Recent Developments
9.14 Pfizer
9.14.1 Pfizer Basic Information
9.14.2 Pfizer Biologic Medications for Psoriasis Product Overview
9.14.3 Pfizer Biologic Medications for Psoriasis Product Market Performance
9.14.4 Pfizer Business Overview
9.14.5 Pfizer Recent Developments
9.15 Samsung Bioepis
9.15.1 Samsung Bioepis Basic Information
9.15.2 Samsung Bioepis Biologic Medications for Psoriasis Product Overview
9.15.3 Samsung Bioepis Biologic Medications for Psoriasis Product Market Performance
9.15.4 Samsung Bioepis Business Overview
9.15.5 Samsung Bioepis Recent Developments
9.16 Qilu Pharmaceutical
9.16.1 Qilu Pharmaceutical Basic Information
9.16.2 Qilu Pharmaceutical Biologic Medications for Psoriasis Product Overview
9.16.3 Qilu Pharmaceutical Biologic Medications for Psoriasis Product Market Performance
9.16.4 Qilu Pharmaceutical Business Overview
9.16.5 Qilu Pharmaceutical Recent Developments
9.17 Hanwha Chemical
9.17.1 Hanwha Chemical Basic Information
9.17.2 Hanwha Chemical Biologic Medications for Psoriasis Product Overview
9.17.3 Hanwha Chemical Biologic Medications for Psoriasis Product Market Performance
9.17.4 Hanwha Chemical Business Overview
9.17.5 Hanwha Chemical Recent Developments
9.18 China Medical System
9.18.1 China Medical System Basic Information
9.18.2 China Medical System Biologic Medications for Psoriasis Product Overview
9.18.3 China Medical System Biologic Medications for Psoriasis Product Market Performance
9.18.4 China Medical System Business Overview
9.18.5 China Medical System Recent Developments
10 BIOLOGIC MEDICATIONS FOR PSORIASIS MARKET FORECAST BY REGION
10.1 Global Biologic Medications for Psoriasis Market Size Forecast
10.2 Global Biologic Medications for Psoriasis Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Biologic Medications for Psoriasis Market Size Forecast by Country
10.2.3 Asia Pacific Biologic Medications for Psoriasis Market Size Forecast by Region
10.2.4 South America Biologic Medications for Psoriasis Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Sales of Biologic Medications for Psoriasis by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
11.1 Global Biologic Medications for Psoriasis Market Forecast by Type (2026-2033)
11.2 Global Biologic Medications for Psoriasis Market Forecast by Application (2026-2033)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Biologic Medications for Psoriasis
1.2 Key Market Segments
1.2.1 Biologic Medications for Psoriasis Segment by Type
1.2.2 Biologic Medications for Psoriasis Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 BIOLOGIC MEDICATIONS FOR PSORIASIS MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 BIOLOGIC MEDICATIONS FOR PSORIASIS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Biologic Medications for Psoriasis Product Life Cycle
3.3 Global Biologic Medications for Psoriasis Revenue Market Share by Company (2020-2025)
3.4 Biologic Medications for Psoriasis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 Biologic Medications for Psoriasis Company Headquarters, Area Served, Product Type
3.6 Biologic Medications for Psoriasis Market Competitive Situation and Trends
3.6.1 Biologic Medications for Psoriasis Market Concentration Rate
3.6.2 Global 5 and 10 Largest Biologic Medications for Psoriasis Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 BIOLOGIC MEDICATIONS FOR PSORIASIS VALUE CHAIN ANALYSIS
4.1 Biologic Medications for Psoriasis Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF BIOLOGIC MEDICATIONS FOR PSORIASIS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Biologic Medications for Psoriasis Market Porter's Five Forces Analysis
6 BIOLOGIC MEDICATIONS FOR PSORIASIS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Biologic Medications for Psoriasis Market Size Market Share by Type (2020-2025)
6.3 Global Biologic Medications for Psoriasis Market Size Growth Rate by Type (2021-2025)
7 BIOLOGIC MEDICATIONS FOR PSORIASIS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Biologic Medications for Psoriasis Market Size (M USD) by Application (2020-2025)
7.3 Global Biologic Medications for Psoriasis Sales Growth Rate by Application (2020-2025)
8 BIOLOGIC MEDICATIONS FOR PSORIASIS MARKET SEGMENTATION BY REGION
8.1 Global Biologic Medications for Psoriasis Market Size by Region
8.1.1 Global Biologic Medications for Psoriasis Market Size by Region
8.1.2 Global Biologic Medications for Psoriasis Market Size Market Share by Region
8.2 North America
8.2.1 North America Biologic Medications for Psoriasis Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Biologic Medications for Psoriasis Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Spain
8.4 Asia Pacific
8.4.1 Asia Pacific Biologic Medications for Psoriasis Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Biologic Medications for Psoriasis Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Biologic Medications for Psoriasis Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Bristol-Myers Squibb
9.1.1 Bristol-Myers Squibb Basic Information
9.1.2 Bristol-Myers Squibb Biologic Medications for Psoriasis Product Overview
9.1.3 Bristol-Myers Squibb Biologic Medications for Psoriasis Product Market Performance
9.1.4 Bristol-Myers Squibb SWOT Analysis
9.1.5 Bristol-Myers Squibb Business Overview
9.1.6 Bristol-Myers Squibb Recent Developments
9.2 Amgen
9.2.1 Amgen Basic Information
9.2.2 Amgen Biologic Medications for Psoriasis Product Overview
9.2.3 Amgen Biologic Medications for Psoriasis Product Market Performance
9.2.4 Amgen SWOT Analysis
9.2.5 Amgen Business Overview
9.2.6 Amgen Recent Developments
9.3 Tiefenbacher Pharmaceuticals
9.3.1 Tiefenbacher Pharmaceuticals Basic Information
9.3.2 Tiefenbacher Pharmaceuticals Biologic Medications for Psoriasis Product Overview
9.3.3 Tiefenbacher Pharmaceuticals Biologic Medications for Psoriasis Product Market Performance
9.3.4 Tiefenbacher Pharmaceuticals SWOT Analysis
9.3.5 Tiefenbacher Pharmaceuticals Business Overview
9.3.6 Tiefenbacher Pharmaceuticals Recent Developments
9.4 UCB
9.4.1 UCB Basic Information
9.4.2 UCB Biologic Medications for Psoriasis Product Overview
9.4.3 UCB Biologic Medications for Psoriasis Product Market Performance
9.4.4 UCB Business Overview
9.4.5 UCB Recent Developments
9.5 Janssen Biotech
9.5.1 Janssen Biotech Basic Information
9.5.2 Janssen Biotech Biologic Medications for Psoriasis Product Overview
9.5.3 Janssen Biotech Biologic Medications for Psoriasis Product Market Performance
9.5.4 Janssen Biotech Business Overview
9.5.5 Janssen Biotech Recent Developments
9.6 Eli Lilly
9.6.1 Eli Lilly Basic Information
9.6.2 Eli Lilly Biologic Medications for Psoriasis Product Overview
9.6.3 Eli Lilly Biologic Medications for Psoriasis Product Market Performance
9.6.4 Eli Lilly Business Overview
9.6.5 Eli Lilly Recent Developments
9.7 AbbVie Biotechnology
9.7.1 AbbVie Biotechnology Basic Information
9.7.2 AbbVie Biotechnology Biologic Medications for Psoriasis Product Overview
9.7.3 AbbVie Biotechnology Biologic Medications for Psoriasis Product Market Performance
9.7.4 AbbVie Biotechnology Business Overview
9.7.5 AbbVie Biotechnology Recent Developments
9.8 Dalian Yawei Pharmaceutical
9.8.1 Dalian Yawei Pharmaceutical Basic Information
9.8.2 Dalian Yawei Pharmaceutical Biologic Medications for Psoriasis Product Overview
9.8.3 Dalian Yawei Pharmaceutical Biologic Medications for Psoriasis Product Market Performance
9.8.4 Dalian Yawei Pharmaceutical Business Overview
9.8.5 Dalian Yawei Pharmaceutical Recent Developments
9.9 Novartis
9.9.1 Novartis Basic Information
9.9.2 Novartis Biologic Medications for Psoriasis Product Overview
9.9.3 Novartis Biologic Medications for Psoriasis Product Market Performance
9.9.4 Novartis Business Overview
9.9.5 Novartis Recent Developments
9.10 Ortho Dermatologics
9.10.1 Ortho Dermatologics Basic Information
9.10.2 Ortho Dermatologics Biologic Medications for Psoriasis Product Overview
9.10.3 Ortho Dermatologics Biologic Medications for Psoriasis Product Market Performance
9.10.4 Ortho Dermatologics Business Overview
9.10.5 Ortho Dermatologics Recent Developments
9.11 LEO Pharma
9.11.1 LEO Pharma Basic Information
9.11.2 LEO Pharma Biologic Medications for Psoriasis Product Overview
9.11.3 LEO Pharma Biologic Medications for Psoriasis Product Market Performance
9.11.4 LEO Pharma Business Overview
9.11.5 LEO Pharma Recent Developments
9.12 Kyowa Kirin
9.12.1 Kyowa Kirin Basic Information
9.12.2 Kyowa Kirin Biologic Medications for Psoriasis Product Overview
9.12.3 Kyowa Kirin Biologic Medications for Psoriasis Product Market Performance
9.12.4 Kyowa Kirin Business Overview
9.12.5 Kyowa Kirin Recent Developments
9.13 Boehringer Ingelheim Pharmaceuticals
9.13.1 Boehringer Ingelheim Pharmaceuticals Basic Information
9.13.2 Boehringer Ingelheim Pharmaceuticals Biologic Medications for Psoriasis Product Overview
9.13.3 Boehringer Ingelheim Pharmaceuticals Biologic Medications for Psoriasis Product Market Performance
9.13.4 Boehringer Ingelheim Pharmaceuticals Business Overview
9.13.5 Boehringer Ingelheim Pharmaceuticals Recent Developments
9.14 Pfizer
9.14.1 Pfizer Basic Information
9.14.2 Pfizer Biologic Medications for Psoriasis Product Overview
9.14.3 Pfizer Biologic Medications for Psoriasis Product Market Performance
9.14.4 Pfizer Business Overview
9.14.5 Pfizer Recent Developments
9.15 Samsung Bioepis
9.15.1 Samsung Bioepis Basic Information
9.15.2 Samsung Bioepis Biologic Medications for Psoriasis Product Overview
9.15.3 Samsung Bioepis Biologic Medications for Psoriasis Product Market Performance
9.15.4 Samsung Bioepis Business Overview
9.15.5 Samsung Bioepis Recent Developments
9.16 Qilu Pharmaceutical
9.16.1 Qilu Pharmaceutical Basic Information
9.16.2 Qilu Pharmaceutical Biologic Medications for Psoriasis Product Overview
9.16.3 Qilu Pharmaceutical Biologic Medications for Psoriasis Product Market Performance
9.16.4 Qilu Pharmaceutical Business Overview
9.16.5 Qilu Pharmaceutical Recent Developments
9.17 Hanwha Chemical
9.17.1 Hanwha Chemical Basic Information
9.17.2 Hanwha Chemical Biologic Medications for Psoriasis Product Overview
9.17.3 Hanwha Chemical Biologic Medications for Psoriasis Product Market Performance
9.17.4 Hanwha Chemical Business Overview
9.17.5 Hanwha Chemical Recent Developments
9.18 China Medical System
9.18.1 China Medical System Basic Information
9.18.2 China Medical System Biologic Medications for Psoriasis Product Overview
9.18.3 China Medical System Biologic Medications for Psoriasis Product Market Performance
9.18.4 China Medical System Business Overview
9.18.5 China Medical System Recent Developments
10 BIOLOGIC MEDICATIONS FOR PSORIASIS MARKET FORECAST BY REGION
10.1 Global Biologic Medications for Psoriasis Market Size Forecast
10.2 Global Biologic Medications for Psoriasis Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Biologic Medications for Psoriasis Market Size Forecast by Country
10.2.3 Asia Pacific Biologic Medications for Psoriasis Market Size Forecast by Region
10.2.4 South America Biologic Medications for Psoriasis Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Sales of Biologic Medications for Psoriasis by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
11.1 Global Biologic Medications for Psoriasis Market Forecast by Type (2026-2033)
11.2 Global Biologic Medications for Psoriasis Market Forecast by Application (2026-2033)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Biologic Medications for Psoriasis Market Size Comparison by Region (M USD)
Table 5. Global Biologic Medications for Psoriasis Revenue (M USD) by Company (2020-2025)
Table 6. Global Biologic Medications for Psoriasis Revenue Share by Company (2020-2025)
Table 7. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologic Medications for Psoriasis as of 2024)
Table 8. Biologic Medications for Psoriasis Company Headquarters and Area Served
Table 9. Company Biologic Medications for Psoriasis Product Type
Table 10. Global Biologic Medications for Psoriasis Company Market Concentration Ratio (CR5 and HHI)
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. Midstream Market Analysis
Table 13. Downstream Customer Analysis
Table 14. Key Development Trends
Table 15. Driving Factors
Table 16. Biologic Medications for Psoriasis Market Challenges
Table 17. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 18. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 19. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 20. Global Biologic Medications for Psoriasis Market Size by Type (M USD)
Table 21. Global Biologic Medications for Psoriasis Market Size (M USD) by Type (2020-2025)
Table 22. Global Biologic Medications for Psoriasis Market Size Share by Type (2020-2025)
Table 23. Global Biologic Medications for Psoriasis Market Size Growth Rate by Type (2021-2025)
Table 24. Global Biologic Medications for Psoriasis Market Size by Application
Table 25. Global Biologic Medications for Psoriasis Market Size by Application (2020-2025) & (M USD)
Table 26. Global Biologic Medications for Psoriasis Market Share by Application (2020-2025)
Table 27. Global Biologic Medications for Psoriasis Sales Growth Rate by Application (2020-2025)
Table 28. Global Biologic Medications for Psoriasis Market Size by Region (2020-2025) & (M USD)
Table 29. Global Biologic Medications for Psoriasis Market Size Market Share by Region (2020-2025)
Table 30. North America Biologic Medications for Psoriasis Market Size by Country (2020-2025) & (M USD)
Table 31. Europe Biologic Medications for Psoriasis Market Size by Country (2020-2025) & (M USD)
Table 32. Asia Pacific Biologic Medications for Psoriasis Market Size by Region (2020-2025) & (M USD)
Table 33. South America Biologic Medications for Psoriasis Market Size by Country (2020-2025) & (M USD)
Table 34. Middle East and Africa Biologic Medications for Psoriasis Market Size by Region (2020-2025) & (M USD)
Table 35. Bristol-Myers Squibb Basic Information
Table 36. Bristol-Myers Squibb Biologic Medications for Psoriasis Product Overview
Table 37. Bristol-Myers Squibb Biologic Medications for Psoriasis Revenue (M USD) and Gross Margin (2020-2025)
Table 38. Bristol-Myers Squibb SWOT Analysis
Table 39. Bristol-Myers Squibb Business Overview
Table 40. Bristol-Myers Squibb Recent Developments
Table 41. Amgen Basic Information
Table 42. Amgen Biologic Medications for Psoriasis Product Overview
Table 43. Amgen Biologic Medications for Psoriasis Revenue (M USD) and Gross Margin (2020-2025)
Table 44. Amgen SWOT Analysis
Table 45. Amgen Business Overview
Table 46. Amgen Recent Developments
Table 47. Tiefenbacher Pharmaceuticals Basic Information
Table 48. Tiefenbacher Pharmaceuticals Biologic Medications for Psoriasis Product Overview
Table 49. Tiefenbacher Pharmaceuticals Biologic Medications for Psoriasis Revenue (M USD) and Gross Margin (2020-2025)
Table 50. Tiefenbacher Pharmaceuticals SWOT Analysis
Table 51. Tiefenbacher Pharmaceuticals Business Overview
Table 52. Tiefenbacher Pharmaceuticals Recent Developments
Table 53. UCB Basic Information
Table 54. UCB Biologic Medications for Psoriasis Product Overview
Table 55. UCB Biologic Medications for Psoriasis Revenue (M USD) and Gross Margin (2020-2025)
Table 56. UCB Business Overview
Table 57. UCB Recent Developments
Table 58. Janssen Biotech Basic Information
Table 59. Janssen Biotech Biologic Medications for Psoriasis Product Overview
Table 60. Janssen Biotech Biologic Medications for Psoriasis Revenue (M USD) and Gross Margin (2020-2025)
Table 61. Janssen Biotech Business Overview
Table 62. Janssen Biotech Recent Developments
Table 63. Eli Lilly Basic Information
Table 64. Eli Lilly Biologic Medications for Psoriasis Product Overview
Table 65. Eli Lilly Biologic Medications for Psoriasis Revenue (M USD) and Gross Margin (2020-2025)
Table 66. Eli Lilly Business Overview
Table 67. Eli Lilly Recent Developments
Table 68. AbbVie Biotechnology Basic Information
Table 69. AbbVie Biotechnology Biologic Medications for Psoriasis Product Overview
Table 70. AbbVie Biotechnology Biologic Medications for Psoriasis Revenue (M USD) and Gross Margin (2020-2025)
Table 71. AbbVie Biotechnology Business Overview
Table 72. AbbVie Biotechnology Recent Developments
Table 73. Dalian Yawei Pharmaceutical Basic Information
Table 74. Dalian Yawei Pharmaceutical Biologic Medications for Psoriasis Product Overview
Table 75. Dalian Yawei Pharmaceutical Biologic Medications for Psoriasis Revenue (M USD) and Gross Margin (2020-2025)
Table 76. Dalian Yawei Pharmaceutical Business Overview
Table 77. Dalian Yawei Pharmaceutical Recent Developments
Table 78. Novartis Basic Information
Table 79. Novartis Biologic Medications for Psoriasis Product Overview
Table 80. Novartis Biologic Medications for Psoriasis Revenue (M USD) and Gross Margin (2020-2025)
Table 81. Novartis Business Overview
Table 82. Novartis Recent Developments
Table 83. Ortho Dermatologics Basic Information
Table 84. Ortho Dermatologics Biologic Medications for Psoriasis Product Overview
Table 85. Ortho Dermatologics Biologic Medications for Psoriasis Revenue (M USD) and Gross Margin (2020-2025)
Table 86. Ortho Dermatologics Business Overview
Table 87. Ortho Dermatologics Recent Developments
Table 88. LEO Pharma Basic Information
Table 89. LEO Pharma Biologic Medications for Psoriasis Product Overview
Table 90. LEO Pharma Biologic Medications for Psoriasis Revenue (M USD) and Gross Margin (2020-2025)
Table 91. LEO Pharma Business Overview
Table 92. LEO Pharma Recent Developments
Table 93. Kyowa Kirin Basic Information
Table 94. Kyowa Kirin Biologic Medications for Psoriasis Product Overview
Table 95. Kyowa Kirin Biologic Medications for Psoriasis Revenue (M USD) and Gross Margin (2020-2025)
Table 96. Kyowa Kirin Business Overview
Table 97. Kyowa Kirin Recent Developments
Table 98. Boehringer Ingelheim Pharmaceuticals Basic Information
Table 99. Boehringer Ingelheim Pharmaceuticals Biologic Medications for Psoriasis Product Overview
Table 100. Boehringer Ingelheim Pharmaceuticals Biologic Medications for Psoriasis Revenue (M USD) and Gross Margin (2020-2025)
Table 101. Boehringer Ingelheim Pharmaceuticals Business Overview
Table 102. Boehringer Ingelheim Pharmaceuticals Recent Developments
Table 103. Pfizer Basic Information
Table 104. Pfizer Biologic Medications for Psoriasis Product Overview
Table 105. Pfizer Biologic Medications for Psoriasis Revenue (M USD) and Gross Margin (2020-2025)
Table 106. Pfizer Business Overview
Table 107. Pfizer Recent Developments
Table 108. Samsung Bioepis Basic Information
Table 109. Samsung Bioepis Biologic Medications for Psoriasis Product Overview
Table 110. Samsung Bioepis Biologic Medications for Psoriasis Revenue (M USD) and Gross Margin (2020-2025)
Table 111. Samsung Bioepis Business Overview
Table 112. Samsung Bioepis Recent Developments
Table 113. Qilu Pharmaceutical Basic Information
Table 114. Qilu Pharmaceutical Biologic Medications for Psoriasis Product Overview
Table 115. Qilu Pharmaceutical Biologic Medications for Psoriasis Revenue (M USD) and Gross Margin (2020-2025)
Table 116. Qilu Pharmaceutical Business Overview
Table 117. Qilu Pharmaceutical Recent Developments
Table 118. Hanwha Chemical Basic Information
Table 119. Hanwha Chemical Biologic Medications for Psoriasis Product Overview
Table 120. Hanwha Chemical Biologic Medications for Psoriasis Revenue (M USD) and Gross Margin (2020-2025)
Table 121. Hanwha Chemical Business Overview
Table 122. Hanwha Chemical Recent Developments
Table 123. China Medical System Basic Information
Table 124. China Medical System Biologic Medications for Psoriasis Product Overview
Table 125. China Medical System Biologic Medications for Psoriasis Revenue (M USD) and Gross Margin (2020-2025)
Table 126. China Medical System Business Overview
Table 127. China Medical System Recent Developments
Table 128. Global Biologic Medications for Psoriasis Market Size Forecast by Region (2026-2033) & (M USD)
Table 129. North America Biologic Medications for Psoriasis Market Size Forecast by Country (2026-2033) & (M USD)
Table 130. Europe Biologic Medications for Psoriasis Market Size Forecast by Country (2026-2033) & (M USD)
Table 131. Asia Pacific Biologic Medications for Psoriasis Market Size Forecast by Region (2026-2033) & (M USD)
Table 132. South America Biologic Medications for Psoriasis Market Size Forecast by Country (2026-2033) & (M USD)
Table 133. Middle East and Africa Biologic Medications for Psoriasis Market Size Forecast by Country (2026-2033) & (M USD)
Table 134. Global Biologic Medications for Psoriasis Market Size Forecast by Type (2026-2033) & (M USD)
Table 135. Global Biologic Medications for Psoriasis Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Biologic Medications for Psoriasis Market Size Comparison by Region (M USD)
Table 5. Global Biologic Medications for Psoriasis Revenue (M USD) by Company (2020-2025)
Table 6. Global Biologic Medications for Psoriasis Revenue Share by Company (2020-2025)
Table 7. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologic Medications for Psoriasis as of 2024)
Table 8. Biologic Medications for Psoriasis Company Headquarters and Area Served
Table 9. Company Biologic Medications for Psoriasis Product Type
Table 10. Global Biologic Medications for Psoriasis Company Market Concentration Ratio (CR5 and HHI)
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. Midstream Market Analysis
Table 13. Downstream Customer Analysis
Table 14. Key Development Trends
Table 15. Driving Factors
Table 16. Biologic Medications for Psoriasis Market Challenges
Table 17. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 18. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 19. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 20. Global Biologic Medications for Psoriasis Market Size by Type (M USD)
Table 21. Global Biologic Medications for Psoriasis Market Size (M USD) by Type (2020-2025)
Table 22. Global Biologic Medications for Psoriasis Market Size Share by Type (2020-2025)
Table 23. Global Biologic Medications for Psoriasis Market Size Growth Rate by Type (2021-2025)
Table 24. Global Biologic Medications for Psoriasis Market Size by Application
Table 25. Global Biologic Medications for Psoriasis Market Size by Application (2020-2025) & (M USD)
Table 26. Global Biologic Medications for Psoriasis Market Share by Application (2020-2025)
Table 27. Global Biologic Medications for Psoriasis Sales Growth Rate by Application (2020-2025)
Table 28. Global Biologic Medications for Psoriasis Market Size by Region (2020-2025) & (M USD)
Table 29. Global Biologic Medications for Psoriasis Market Size Market Share by Region (2020-2025)
Table 30. North America Biologic Medications for Psoriasis Market Size by Country (2020-2025) & (M USD)
Table 31. Europe Biologic Medications for Psoriasis Market Size by Country (2020-2025) & (M USD)
Table 32. Asia Pacific Biologic Medications for Psoriasis Market Size by Region (2020-2025) & (M USD)
Table 33. South America Biologic Medications for Psoriasis Market Size by Country (2020-2025) & (M USD)
Table 34. Middle East and Africa Biologic Medications for Psoriasis Market Size by Region (2020-2025) & (M USD)
Table 35. Bristol-Myers Squibb Basic Information
Table 36. Bristol-Myers Squibb Biologic Medications for Psoriasis Product Overview
Table 37. Bristol-Myers Squibb Biologic Medications for Psoriasis Revenue (M USD) and Gross Margin (2020-2025)
Table 38. Bristol-Myers Squibb SWOT Analysis
Table 39. Bristol-Myers Squibb Business Overview
Table 40. Bristol-Myers Squibb Recent Developments
Table 41. Amgen Basic Information
Table 42. Amgen Biologic Medications for Psoriasis Product Overview
Table 43. Amgen Biologic Medications for Psoriasis Revenue (M USD) and Gross Margin (2020-2025)
Table 44. Amgen SWOT Analysis
Table 45. Amgen Business Overview
Table 46. Amgen Recent Developments
Table 47. Tiefenbacher Pharmaceuticals Basic Information
Table 48. Tiefenbacher Pharmaceuticals Biologic Medications for Psoriasis Product Overview
Table 49. Tiefenbacher Pharmaceuticals Biologic Medications for Psoriasis Revenue (M USD) and Gross Margin (2020-2025)
Table 50. Tiefenbacher Pharmaceuticals SWOT Analysis
Table 51. Tiefenbacher Pharmaceuticals Business Overview
Table 52. Tiefenbacher Pharmaceuticals Recent Developments
Table 53. UCB Basic Information
Table 54. UCB Biologic Medications for Psoriasis Product Overview
Table 55. UCB Biologic Medications for Psoriasis Revenue (M USD) and Gross Margin (2020-2025)
Table 56. UCB Business Overview
Table 57. UCB Recent Developments
Table 58. Janssen Biotech Basic Information
Table 59. Janssen Biotech Biologic Medications for Psoriasis Product Overview
Table 60. Janssen Biotech Biologic Medications for Psoriasis Revenue (M USD) and Gross Margin (2020-2025)
Table 61. Janssen Biotech Business Overview
Table 62. Janssen Biotech Recent Developments
Table 63. Eli Lilly Basic Information
Table 64. Eli Lilly Biologic Medications for Psoriasis Product Overview
Table 65. Eli Lilly Biologic Medications for Psoriasis Revenue (M USD) and Gross Margin (2020-2025)
Table 66. Eli Lilly Business Overview
Table 67. Eli Lilly Recent Developments
Table 68. AbbVie Biotechnology Basic Information
Table 69. AbbVie Biotechnology Biologic Medications for Psoriasis Product Overview
Table 70. AbbVie Biotechnology Biologic Medications for Psoriasis Revenue (M USD) and Gross Margin (2020-2025)
Table 71. AbbVie Biotechnology Business Overview
Table 72. AbbVie Biotechnology Recent Developments
Table 73. Dalian Yawei Pharmaceutical Basic Information
Table 74. Dalian Yawei Pharmaceutical Biologic Medications for Psoriasis Product Overview
Table 75. Dalian Yawei Pharmaceutical Biologic Medications for Psoriasis Revenue (M USD) and Gross Margin (2020-2025)
Table 76. Dalian Yawei Pharmaceutical Business Overview
Table 77. Dalian Yawei Pharmaceutical Recent Developments
Table 78. Novartis Basic Information
Table 79. Novartis Biologic Medications for Psoriasis Product Overview
Table 80. Novartis Biologic Medications for Psoriasis Revenue (M USD) and Gross Margin (2020-2025)
Table 81. Novartis Business Overview
Table 82. Novartis Recent Developments
Table 83. Ortho Dermatologics Basic Information
Table 84. Ortho Dermatologics Biologic Medications for Psoriasis Product Overview
Table 85. Ortho Dermatologics Biologic Medications for Psoriasis Revenue (M USD) and Gross Margin (2020-2025)
Table 86. Ortho Dermatologics Business Overview
Table 87. Ortho Dermatologics Recent Developments
Table 88. LEO Pharma Basic Information
Table 89. LEO Pharma Biologic Medications for Psoriasis Product Overview
Table 90. LEO Pharma Biologic Medications for Psoriasis Revenue (M USD) and Gross Margin (2020-2025)
Table 91. LEO Pharma Business Overview
Table 92. LEO Pharma Recent Developments
Table 93. Kyowa Kirin Basic Information
Table 94. Kyowa Kirin Biologic Medications for Psoriasis Product Overview
Table 95. Kyowa Kirin Biologic Medications for Psoriasis Revenue (M USD) and Gross Margin (2020-2025)
Table 96. Kyowa Kirin Business Overview
Table 97. Kyowa Kirin Recent Developments
Table 98. Boehringer Ingelheim Pharmaceuticals Basic Information
Table 99. Boehringer Ingelheim Pharmaceuticals Biologic Medications for Psoriasis Product Overview
Table 100. Boehringer Ingelheim Pharmaceuticals Biologic Medications for Psoriasis Revenue (M USD) and Gross Margin (2020-2025)
Table 101. Boehringer Ingelheim Pharmaceuticals Business Overview
Table 102. Boehringer Ingelheim Pharmaceuticals Recent Developments
Table 103. Pfizer Basic Information
Table 104. Pfizer Biologic Medications for Psoriasis Product Overview
Table 105. Pfizer Biologic Medications for Psoriasis Revenue (M USD) and Gross Margin (2020-2025)
Table 106. Pfizer Business Overview
Table 107. Pfizer Recent Developments
Table 108. Samsung Bioepis Basic Information
Table 109. Samsung Bioepis Biologic Medications for Psoriasis Product Overview
Table 110. Samsung Bioepis Biologic Medications for Psoriasis Revenue (M USD) and Gross Margin (2020-2025)
Table 111. Samsung Bioepis Business Overview
Table 112. Samsung Bioepis Recent Developments
Table 113. Qilu Pharmaceutical Basic Information
Table 114. Qilu Pharmaceutical Biologic Medications for Psoriasis Product Overview
Table 115. Qilu Pharmaceutical Biologic Medications for Psoriasis Revenue (M USD) and Gross Margin (2020-2025)
Table 116. Qilu Pharmaceutical Business Overview
Table 117. Qilu Pharmaceutical Recent Developments
Table 118. Hanwha Chemical Basic Information
Table 119. Hanwha Chemical Biologic Medications for Psoriasis Product Overview
Table 120. Hanwha Chemical Biologic Medications for Psoriasis Revenue (M USD) and Gross Margin (2020-2025)
Table 121. Hanwha Chemical Business Overview
Table 122. Hanwha Chemical Recent Developments
Table 123. China Medical System Basic Information
Table 124. China Medical System Biologic Medications for Psoriasis Product Overview
Table 125. China Medical System Biologic Medications for Psoriasis Revenue (M USD) and Gross Margin (2020-2025)
Table 126. China Medical System Business Overview
Table 127. China Medical System Recent Developments
Table 128. Global Biologic Medications for Psoriasis Market Size Forecast by Region (2026-2033) & (M USD)
Table 129. North America Biologic Medications for Psoriasis Market Size Forecast by Country (2026-2033) & (M USD)
Table 130. Europe Biologic Medications for Psoriasis Market Size Forecast by Country (2026-2033) & (M USD)
Table 131. Asia Pacific Biologic Medications for Psoriasis Market Size Forecast by Region (2026-2033) & (M USD)
Table 132. South America Biologic Medications for Psoriasis Market Size Forecast by Country (2026-2033) & (M USD)
Table 133. Middle East and Africa Biologic Medications for Psoriasis Market Size Forecast by Country (2026-2033) & (M USD)
Table 134. Global Biologic Medications for Psoriasis Market Size Forecast by Type (2026-2033) & (M USD)
Table 135. Global Biologic Medications for Psoriasis Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Industry Chain of Biologic Medications for Psoriasis
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Biologic Medications for Psoriasis Market Size (M USD), 2024-2033
Figure 5. Global Biologic Medications for Psoriasis Market Size (M USD) (2020-2033)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Biologic Medications for Psoriasis Market Size by Country (M USD)
Figure 10. Company Assessment Quadrant
Figure 11. Global Biologic Medications for Psoriasis Product Life Cycle
Figure 12. Global Biologic Medications for Psoriasis Revenue Share by Company in 2024
Figure 13. Biologic Medications for Psoriasis Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 14. The Global 5 and 10 Largest Players: Market Share by Biologic Medications for Psoriasis Revenue in 2024
Figure 15. Value Chain Map of Biologic Medications for Psoriasis
Figure 16. Global Biologic Medications for Psoriasis Market PEST Analysis
Figure 17. Global Biologic Medications for Psoriasis Market Porter's Five Forces Analysis
Figure 18. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 19. Global Biologic Medications for Psoriasis Market Share by Type
Figure 20. Market Size Share of Biologic Medications for Psoriasis by Type (2020-2025)
Figure 21. Market Size Share of Biologic Medications for Psoriasis by Type in 2024
Figure 22. Global Biologic Medications for Psoriasis Market Size Growth Rate by Type (2021-2025)
Figure 23. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 24. Global Biologic Medications for Psoriasis Market Share by Application
Figure 25. Global Biologic Medications for Psoriasis Market Share by Application (2020-2025)
Figure 26. Global Biologic Medications for Psoriasis Market Share by Application in 2024
Figure 27. Global Biologic Medications for Psoriasis Sales Growth Rate by Application (2020-2025)
Figure 28. Global Biologic Medications for Psoriasis Market Size Market Share by Region (2020-2025)
Figure 29. North America Biologic Medications for Psoriasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 30. North America Biologic Medications for Psoriasis Market Size Market Share by Country in 2024
Figure 31. U.S. Biologic Medications for Psoriasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 32. Canada Biologic Medications for Psoriasis Market Size (M USD) and Growth Rate (2020-2025)
Figure 33. Mexico Biologic Medications for Psoriasis Market Size (M USD) and Growth Rate (2020-2025)
Figure 34. Europe Biologic Medications for Psoriasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 35. Europe Biologic Medications for Psoriasis Market Share by Country in 2024
Figure 36. Germany Biologic Medications for Psoriasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 37. France Biologic Medications for Psoriasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 38. U.K. Biologic Medications for Psoriasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 39. Italy Biologic Medications for Psoriasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 40. Spain Biologic Medications for Psoriasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 41. Asia Pacific Biologic Medications for Psoriasis Market Size and Growth Rate (M USD)
Figure 42. Asia Pacific Biologic Medications for Psoriasis Market Size Market Share by Region in 2024
Figure 43. China Biologic Medications for Psoriasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. Japan Biologic Medications for Psoriasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 45. South Korea Biologic Medications for Psoriasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. India Biologic Medications for Psoriasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Southeast Asia Biologic Medications for Psoriasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 48. South America Biologic Medications for Psoriasis Market Size and Growth Rate (M USD)
Figure 49. South America Biologic Medications for Psoriasis Market Size Market Share by Country in 2024
Figure 50. Brazil Biologic Medications for Psoriasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Argentina Biologic Medications for Psoriasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 52. Columbia Biologic Medications for Psoriasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 53. Middle East and Africa Biologic Medications for Psoriasis Market Size and Growth Rate (M USD)
Figure 54. Middle East and Africa Biologic Medications for Psoriasis Market Size Market Share by Region in 2024
Figure 55. Saudi Arabia Biologic Medications for Psoriasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 56. UAE Biologic Medications for Psoriasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. Egypt Biologic Medications for Psoriasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. Nigeria Biologic Medications for Psoriasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. South Africa Biologic Medications for Psoriasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Global Biologic Medications for Psoriasis Market Size Forecast (2020-2033) & (M USD)
Figure 61. Global Biologic Medications for Psoriasis Market Share Forecast by Type (2026-2033)
Figure 62. Global Biologic Medications for Psoriasis Market Share Forecast by Application (2026-2033)
Figure 1. Industry Chain of Biologic Medications for Psoriasis
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Biologic Medications for Psoriasis Market Size (M USD), 2024-2033
Figure 5. Global Biologic Medications for Psoriasis Market Size (M USD) (2020-2033)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Biologic Medications for Psoriasis Market Size by Country (M USD)
Figure 10. Company Assessment Quadrant
Figure 11. Global Biologic Medications for Psoriasis Product Life Cycle
Figure 12. Global Biologic Medications for Psoriasis Revenue Share by Company in 2024
Figure 13. Biologic Medications for Psoriasis Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 14. The Global 5 and 10 Largest Players: Market Share by Biologic Medications for Psoriasis Revenue in 2024
Figure 15. Value Chain Map of Biologic Medications for Psoriasis
Figure 16. Global Biologic Medications for Psoriasis Market PEST Analysis
Figure 17. Global Biologic Medications for Psoriasis Market Porter's Five Forces Analysis
Figure 18. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 19. Global Biologic Medications for Psoriasis Market Share by Type
Figure 20. Market Size Share of Biologic Medications for Psoriasis by Type (2020-2025)
Figure 21. Market Size Share of Biologic Medications for Psoriasis by Type in 2024
Figure 22. Global Biologic Medications for Psoriasis Market Size Growth Rate by Type (2021-2025)
Figure 23. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 24. Global Biologic Medications for Psoriasis Market Share by Application
Figure 25. Global Biologic Medications for Psoriasis Market Share by Application (2020-2025)
Figure 26. Global Biologic Medications for Psoriasis Market Share by Application in 2024
Figure 27. Global Biologic Medications for Psoriasis Sales Growth Rate by Application (2020-2025)
Figure 28. Global Biologic Medications for Psoriasis Market Size Market Share by Region (2020-2025)
Figure 29. North America Biologic Medications for Psoriasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 30. North America Biologic Medications for Psoriasis Market Size Market Share by Country in 2024
Figure 31. U.S. Biologic Medications for Psoriasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 32. Canada Biologic Medications for Psoriasis Market Size (M USD) and Growth Rate (2020-2025)
Figure 33. Mexico Biologic Medications for Psoriasis Market Size (M USD) and Growth Rate (2020-2025)
Figure 34. Europe Biologic Medications for Psoriasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 35. Europe Biologic Medications for Psoriasis Market Share by Country in 2024
Figure 36. Germany Biologic Medications for Psoriasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 37. France Biologic Medications for Psoriasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 38. U.K. Biologic Medications for Psoriasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 39. Italy Biologic Medications for Psoriasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 40. Spain Biologic Medications for Psoriasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 41. Asia Pacific Biologic Medications for Psoriasis Market Size and Growth Rate (M USD)
Figure 42. Asia Pacific Biologic Medications for Psoriasis Market Size Market Share by Region in 2024
Figure 43. China Biologic Medications for Psoriasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. Japan Biologic Medications for Psoriasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 45. South Korea Biologic Medications for Psoriasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. India Biologic Medications for Psoriasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Southeast Asia Biologic Medications for Psoriasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 48. South America Biologic Medications for Psoriasis Market Size and Growth Rate (M USD)
Figure 49. South America Biologic Medications for Psoriasis Market Size Market Share by Country in 2024
Figure 50. Brazil Biologic Medications for Psoriasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Argentina Biologic Medications for Psoriasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 52. Columbia Biologic Medications for Psoriasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 53. Middle East and Africa Biologic Medications for Psoriasis Market Size and Growth Rate (M USD)
Figure 54. Middle East and Africa Biologic Medications for Psoriasis Market Size Market Share by Region in 2024
Figure 55. Saudi Arabia Biologic Medications for Psoriasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 56. UAE Biologic Medications for Psoriasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. Egypt Biologic Medications for Psoriasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. Nigeria Biologic Medications for Psoriasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. South Africa Biologic Medications for Psoriasis Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Global Biologic Medications for Psoriasis Market Size Forecast (2020-2033) & (M USD)
Figure 61. Global Biologic Medications for Psoriasis Market Share Forecast by Type (2026-2033)
Figure 62. Global Biologic Medications for Psoriasis Market Share Forecast by Application (2026-2033)
